Mometasone furoate-loaded aspasomal gel for topical treatment of psoriasis: formulation, optimization, in vitro and in vivo performance

References

• Şenyiğit T, Padula C, Özer Ö, et al. Different approaches for improving skin accumulation of topical corticosteroids. Int J Pharm. 2009;380:155–160.
   PubMed Web of Science ®Google Scholar
• Rahman M, Alam K, Zaki Ahmad M, et al. Classical to current approach for treatment of psoriasis: a review. Endo Meta Immunol Disord Drug Target. 2012;12:287–302.
   PubMedGoogle Scholar
• Chan SA, Hussain F, Lawson LG, et al. Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities. J Dermatol Treat. 2013;24:64–69.
   PubMed Web of Science ®Google Scholar
• Zampetti A, Barone A, Antuzzi D, et al. Topical preparations for the treatment of psoriasis: results of a retrospective study over 15 years. J Dermatol Treat. 2008;19:134–140.
   PubMed Web of Science ®Google Scholar
• Lapolla W, Yentzer BA, Bagel J, et al. A review of phototherapy protocols for psoriasis treatment. J Am Acad Dermatol. 2011;64:936–949.
   PubMed Web of Science ®Google Scholar
• Patrizi A, Raone B, Ravaioli GM. Management of atopic dermatitis: safety and efficacy of phototherapy. Clin Cosmet Investig Dermatol. 2015;8:511–520.
   PubMed Web of Science ®Google Scholar
• Boström Å, Lindman H, Swartling C, et al. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study. Radio Oncol. 2001;59:257–265.
   PubMed Web of Science ®Google Scholar
• Hendricks AJ, Yosipovitch G, Shi VY. Dupilumab use in dermatologic conditions beyond atopic dermatitis: a systematic review. J Dermatol Treat. 2019;12:1–0.
   Google Scholar
• Parnami N, Garg T, Rath G, et al. Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotech. 2014;42:406–412.
   PubMed Web of Science ®Google Scholar
• Shabouri EI. Positively charged nanoparticles for improving the oral bioavailability of cyclosporine-A. Int J Pharm. 2003;249:101–108.
   Google Scholar
• Imam SS, Ahad A, Aqil M, et al. Formulation by design based risperidone nano soft lipid vesicle as a new strategy for enhanced transdermal drug delivery: in-vitro characterization, and in-vivo appraisal. Mater Sci Eng C Mater Biol Appl. 2017;75:1198–1205.
   PubMed Web of Science ®Google Scholar
• Martin FJ, Huang T. STEALTH liposomal technology: current therapies and future directions. Drug Dev Deliv. 2003;3:89–104.
   Google Scholar
• Solanki AB, Parikh JR, Parikh RH, et al. Evaluation of different compositions of niosomes to optimize aceclofenac transdermal delivery. Asia J Pharm Sci. 2010;5:87–95.
   Google Scholar
• Corazza M, Virgili A, Toni G, et al. Mometasone furoate in the treatment of vulvar lichen sclerosus: could its formulation influence efficacy, tolerability and adherence to treatment? J Dermatol Treat. 2018;29:305–309.
   PubMed Web of Science ®Google Scholar
• Tiplica GS, Salavastru CM. Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris. J Euro Acad Dermatol Venereol. 2009;23:905–912.
   PubMed Web of Science ®Google Scholar
• Almgren M, Edwards K, Karlsson G. Cryo transmission electron microscopy of liposomes and related structures. Coll Surf A Physiol Eng Asp. 2000;174:3–21.
   Web of Science ®Google Scholar
• Rahimpour Y, Hamishehkar H. Liposomes in cosmeceutics. Expert Opin Drug Del. 2012;9:443–455.
   PubMed Web of Science ®Google Scholar
• Chawla JS, Amiji MM. Cellular uptake and concentration of tamoxifen upon administration in polycaprolactone nanoparticles. AAPS Pharm Sci. 2002;5:1–7.
   Google Scholar
• Jeong JC, Lee J, Cho K. Effects of crystalline microstructure on drug release behavior of polycaprolactone microspheres. J Control Release. 2003;92:249–258.
   PubMed Web of Science ®Google Scholar
• Jugminder S, Chawla M, Amiji M. Biodegradable poly (caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm. 2002;249:127–138.
   PubMed Web of Science ®Google Scholar
• Shelke S, Shahi S, Jalalpure S, et al. Formulation and evaluation of thermoreversible mucoadhesive in situ gel for intranasal delivery of naratriptan hydrochloride. J Drug Del Sci Tech. 2015;29:238–244.
   Web of Science ®Google Scholar
• Deshmane S, Deshmane S, Shelke S, et al. Enhancement of solubility and bioavailability of ambrisentan by solid dispersion using Daucus carota as a drug carrier: formulation, characterization, in vitro, and in vivo study. Drug Dev Indus Pharm. 2018;44:1001–1011.
   PubMed Web of Science ®Google Scholar
• Stark B, Pabst G, Prassl R. Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: effects of cryoprotectants on structure. Eur J Pharm Sci. 2010;41:546–555.
   PubMed Web of Science ®Google Scholar
• Sugar IP, Michonova-Alexova E, Chong PL. Geometrical properties of gel and fluid clusters in DMPC/DSPC bilayers: Monte Carlo simulation approach using a two-state model. Biophys J. 2001;81:2425–2441.
   PubMed Web of Science ®Google Scholar
• Shelke S, Shahi S, Jalalpure S, et al. Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies. J Liposome Res. 2016;26:313–323.
   PubMed Web of Science ®Google Scholar
• Shelke S, Shahi S, Jadhav K, et al. Thermoreversible nanoethosomal gel for the intranasal delivery of Eletriptan hydrobromide. J Mater Sci Mater Med. 2016;27:103.
   PubMed Web of Science ®Google Scholar
• Pathan IB, Jaware BP, Shelke S, et al. Curcumin loaded ethosomes for transdermal application: formulation, optimization, in-vitro and in-vivo study. J Drug Del Sci Tech. 2018;44:49–57.
   Web of Science ®Google Scholar
• Urbinati G, Marsaud V, Plassat V, et al. Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy. Int J Pharm. 2010;397:184–193.
   PubMedGoogle Scholar
• Khan N, Karodi R, Siddiqui A, et al. Development of anti-acne gel formulation of anthraquinones rich fraction from Rubia cordifolia (Rubiaceae). Int J App Res Nat Prod. 2012;4:28–36.
   Google Scholar
• Patel RP. Formulation optimization and evaluation of mometasone furoate cream. J Pharm Res. 2009;2:1565–1569.
   Google Scholar
• Manconi M, Caddeo C, Sinico C, et al. Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle skin interaction. Eur J Pharm Biopharm. 2011;78:27–35.
   PubMed Web of Science ®Google Scholar
• Fowler SD, Greenspan P. Application of Nile red, a fluorescent hydrophobic probe, for the detection of neutral lipid deposits in tissue section: comparison with oil Red O. J Histochem Cytochem. 1985;33:833–836.
   PubMed Web of Science ®Google Scholar
• Yoshizawa Y, Kono Y, Ogawara K, et al. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy. Int J Pharm. 2011;412:132–141.
   PubMed Web of Science ®Google Scholar
• Nair R, Badivaddin SM, Kumar J, et al. Formulation of microemulsion based vaginal gel-in vitro and in vivo evaluation. Der Pharmacia Lettre. 2010;2:99–105.
   Google Scholar
• Maeda H, Greish K, Fang J. The EPR effect and polymeric drugs: a paradigm shift for cancer chemotherapy in the 21st century. Adv Polym Sci. 2006;193:103–121.
   Web of Science ®Google Scholar
• Honary S, Zahir F. Effect of process factors on the properties of doxycyclin nanovesicles. Trop J Pharm Res. 2012;11:169–175.
   Web of Science ®Google Scholar
• Layek B, Mukherjee B. Tamoxifen citrate encapsulated sustained release liposomes: preparation and evaluation of physicochemical properties. Sci Pharm. 2010;78:507–515.
   PubMedGoogle Scholar
• Riaz M. Liposomes preparation methods. Pak J Pharm Sci. 1996;19:65–77.
   Google Scholar
• Sipai AM, Yadav V, Mamatha Y, et al. Liposomes: an overview. J Pharm Sci Innov. 2012;1:13–21.
   Google Scholar
• Fakhria A, Gilani SJ, Imam SS. Formulation of thymoquinone loaded chitosan nano vesicles: in-vitro evaluation and in-vivo anti-hyperlipidemic assessment. J Drug Del Sci Tech. 2019;50:339–346.
   Web of Science ®Google Scholar
• Ablett K, Thompson AR. Parental, child, and adolescent experience of chronic skin conditions: a meta-ethnography and review of the qualitative literature. Body Image. 2016;19:175–185.
   PubMed Web of Science ®Google Scholar
• Srinath P, Diwan PV. Stealth liposomes: an overview. Ind J Pharmacol. 1994;26:179–184.
   Google Scholar
• Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed. 2006;1:297–315.
   PubMed Web of Science ®Google Scholar
• Shivhare UD, Jain KB, Mathur VB, et al. Formulation development and evaluation of diclofenac sodium gel using water soluble polyacrylamide polymer. Digest J Nanomater Biostruct. 2009;4:285–290
   Web of Science ®Google Scholar
• Vlerken LE, Vyas TK, Amiji MM. Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res. 2007;24:1405–1414.
   PubMed Web of Science ®Google Scholar
• Sharma A, Sharma US. Liposomes in drug delivery: progress and limitations. Int J Pharm. 1997;154:123–140.
   Web of Science ®Google Scholar
• Mokhtar M, Sammour OA, Hammad MA, et al. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008;361:104–111.
   PubMed Web of Science ®Google Scholar
• Maruyama K, Yuda T, Okamoto A, et al. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochem. Biophys Acta. 1992;1128:44–49.
   PubMed Web of Science ®Google Scholar
• Gopinath D, Ravi D, Rao BR, et al. Ascorbyl palmitate vesicles (Aspasomes): formation, characterization and applications. Int J Pharm. 2004;271:95–113.
   PubMed Web of Science ®Google Scholar
• Agrawal Y, Petkar KC, Sawant KK. Development and evaluation and clinical studies of acitretin loaded nanostructured lipid carriers for topical treatment of psoriaisis. Int J Pharm. 2010;401:93–102.
   PubMed Web of Science ®Google Scholar
• Anda H, Todberg T, Skov L, et al. Health-related quality of life in children and adolescents with psoriasis: a systematic review and metaanalysis. Acta Derm Venerol. 2017;97:555–563.
   PubMed Web of Science ®Google Scholar